Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Paul J. Hastings | Chief Executive Officer | 2025-06-18 | 1,790 | $1.79 | $3.20kSell |
Ralph Brandenberger | Chief Technical Officer | 2025-01-15 | 7,447 | $2.20 | $16.38kSell |
Alicia J. Hager | Chief Legal Officer | 2025-01-15 | 9,584 | $2.20 | $21.08kSell |
Paul J. Hastings | Chief Executive Officer | 2025-01-15 | 17,378 | $2.20 | $38.23kSell |
Alyssa Levin | Chief Financial and Business Officer | 2025-01-15 | 5,838 | $2.20 | $12.84kSell |
David Shook | Chief Medical Officer Head of Research Development | 2025-01-15 | 8,638 | $2.20 | $19.00kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 15.21% | 10,805,129 | $24.42M | Institution |
Tang Capital Management LLC | 9.93% | 7,055,576 | $15.95M | Institution |
Blackrock Inc | 5.85% | 4,153,845 | $9.39M | Institution |
Simeon George | 5.63% | 3,999,999 | $9.04M | Insider |
Samsara Biocapital LLC | 5.31% | 3,768,035 | $8.52M | Institution |
Nea Management Company LLC | 5.02% | 3,568,781 | $8.07M | Institution |
Sr One Capital Management LP | 4.69% | 3,333,333 | $7.53M | Institution |
Citadel Advisors LLC | 4.64% | 3,297,824 | $7.45M | Institution |
Glaxosmithkline PLC | 4.44% | 3,150,732 | $7.12M | Insider |
Scott D. Sandell | 4.09% | 2,902,115 | $6.56M | Insider |